What is the recommended treatment for an uncomplicated urinary tract infection, including options for pregnant patients, men, and suspected pyelonephritis?

Treatment of Urinary Tract Infections

Uncomplicated Cystitis (Non-Pregnant Women)

For uncomplicated cystitis in non-pregnant women, nitrofurantoin for 5 days is the preferred first-line treatment, as it effectively treats infection while sparing broader-spectrum agents for more serious infections. 1

First-Line Options:

• Nitrofurantoin: 5-day course (preferred to minimize collateral damage and resistance) 2, 1
• Fosfomycin trometamol: Single 3-gram dose 2
• Pivmecillinam: 3-day course 2
• Trimethoprim-sulfamethoxazole (TMP/SMX): 3-day course - only if local resistance rates are <20% 2

Alternative Options:

• Fluoroquinolones: 3-day course - reserve for when first-line agents cannot be used 2, 1
• Beta-lactams: Less effective than TMP/SMX regardless of duration; not preferred 3

Key Clinical Considerations:

• Symptomatic therapy alone (e.g., ibuprofen) may be considered for mild-to-moderate symptoms in consultation with the patient 2
• No routine post-treatment cultures are needed if symptoms resolve 2
• Urine culture is NOT required for typical presentations; diagnosis can be made clinically based on dysuria, frequency, and urgency without vaginal discharge 2
• Obtain urine culture if: symptoms persist/recur within 4 weeks, atypical presentation, suspected pyelonephritis, or pregnancy 2

---

Uncomplicated Pyelonephritis (Outpatient)

For outpatient management of uncomplicated pyelonephritis, fluoroquinolones (ciprofloxacin 500-750 mg twice daily for 7 days or levofloxacin 750 mg daily for 5 days) are the preferred oral agents, but only when local fluoroquinolone resistance is <10%. 2

Oral Regimens (Outpatient):

• Ciprofloxacin: 500-750 mg twice daily for 7 days 2
• Levofloxacin: 750 mg once daily for 5 days 2
• TMP/SMX: 160/800 mg twice daily for 14 days (if susceptible) 2
• Cefpodoxime: 200 mg twice daily for 10 days 2
• Ceftibuten: 400 mg once daily for 10 days 2

Critical Caveats:

• When using oral cephalosporins empirically, give one initial IV dose of long-acting parenteral antibiotic (e.g., ceftriaxone) because oral cephalosporins achieve significantly lower blood/urinary concentrations than IV route 2
• Avoid nitrofurantoin, fosfomycin, and pivmecillinam for pyelonephritis - insufficient efficacy data 2
• Fluoroquinolone use requires local resistance <10% 2
• Shorter courses (5-7 days) are equivalent to longer therapy for clinical success but have higher recurrence rates at 4-6 weeks 2

---

Uncomplicated Pyelonephritis (Inpatient/IV Therapy)

For hospitalized patients with uncomplicated pyelonephritis, initiate IV fluoroquinolone, aminoglycoside (with or without ampicillin), or extended-spectrum cephalosporin/penicillin based on local resistance patterns. 2

IV Regimens:

• Ciprofloxacin: 400 mg twice daily 2
• Levofloxacin: 750 mg once daily 2
• Ceftriaxone: 1-2 g once daily (higher dose recommended) 2
• Cefepime: 1-2 g twice daily (higher dose recommended) 2
• Gentamicin: 5 mg/kg once daily 2
• Amikacin: 15 mg/kg once daily 2
• Piperacillin/tazobactam: 2.5-4.5 g three times daily 2

Reserve for Multidrug-Resistant Organisms (Only with Culture Data):

• Carbapenems (meropenem 1 g three times daily, imipenem/cilastatin 0.5 g three times daily) 2
• Novel agents (ceftolozane/tazobactam, ceftazidime/avibactam, cefiderocol, meropenem-vaborbactam) 2

Management Principles:

• Reassess at 48-72 hours - if no clinical improvement, obtain imaging and repeat cultures 2, 4
• Switch to oral therapy once clinically improved and able to tolerate oral intake 4
• Total duration: 7 days for beta-lactams, 5-7 days for fluoroquinolones 1

---

UTI in Pregnancy

Pregnant women with UTI require treatment regardless of symptoms due to high risk of ascending infection and adverse pregnancy outcomes; nitrofurantoin, fosfomycin trometamol, and third-generation cephalosporins (particularly cefixime) are the preferred oral agents. 5, 6

Asymptomatic Bacteriuria in Pregnancy:

• Screen once in first trimester with urine culture 6
• Treat if positive with short course of beta-lactams, nitrofurantoin, or fosfomycin 6
• Treatment reduces low birth weight and preterm birth risk 6

Cystitis in Pregnancy (Oral):

• Nitrofurantoin: Preferred oral agent 5, 6
• Fosfomycin trometamol: Single dose option 5, 6
• Cefixime: Third-generation cephalosporin with high compliance and safety 5

Pyelonephritis in Pregnancy (Requires Hospitalization):

• Pregnant patients with pyelonephritis are at significantly elevated risk of severe complications and MUST be admitted for initial IV therapy 4
• Amoxicillin + aminoglycoside: Preferred combination 6
• Third-generation cephalosporins: Alternative option 6
• Carbapenems: For resistant organisms 6

Imaging in Pregnancy:

• Use ultrasound or MRI to avoid radiation exposure to fetus when evaluating for complications 2

---

UTI in Men

UTI in men is considered complicated by definition and requires longer treatment courses; fluoroquinolones or TMP/SMX for 7-14 days are reasonable first-line agents depending on local resistance patterns. 2, 1

Key Differences:

• All UTIs in men are classified as complicated due to anatomic considerations 2
• Same uropathogens (primarily E. coli) with similar susceptibility profiles as women 3
• Longer treatment duration required compared to women 3
• Consider prostatitis in differential diagnosis 3

Treatment Approach:

• Empiric therapy: TMP/SMX or first-generation cephalosporin if local resistance permits 1
• Fluoroquinolones: Alternative for oral therapy 1
• Duration: Minimum 7 days, often 10-14 days 3

---

Complicated UTI

Complicated UTIs require individualized treatment based on severity, risk factors for multidrug resistance, and local resistance patterns; ceftriaxone is the recommended empirical IV choice for patients without risk factors for nosocomial pathogens. 2, 1

Defining Features of Complicated UTI:

• Host factors: Male sex, pregnancy, diabetes, immunosuppression 2
• Anatomic/functional abnormalities: Obstruction, foreign body, incomplete voiding, vesicoureteral reflux 2
• Healthcare-associated: Recent instrumentation, multidrug-resistant organisms, ESBL-producers 2

Treatment Principles:

• Ceftriaxone: Recommended empirical IV choice for patients requiring hospitalization without MDR risk factors 1
• Antipseudomonal agents: Reserve for patients with risk factors for nosocomial pathogens 1
• Carbapenems: Consider empirically only in patients with known MDR risk or early culture results showing resistance 2, 1
• Prompt imaging: Essential to differentiate uncomplicated from obstructive pyelonephritis, which can rapidly progress to urosepsis 2

Duration:

• Beta-lactams: 7 days 1
• Fluoroquinolones: 5-7 days 1
• Insufficient evidence for optimal duration with aminoglycosides, fosfomycin, or TMP/SMX in complicated UTI 1